ALZN
NASDAQ
US
Alzamend Neuro, Inc. - Common Stock
$1.00
▼ $-0.02
(-1.96%)
Vol 94K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$6.9M
ROE
-137.3%
D/E
0.00
Beta
-0.24
52W
$2–$12
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.96 | $-0.58 | +$1.38 |
| Dec 2025 | $-1.99 | $-0.30 | +$1.69 |
| Sep 2025 | $-0.70 | $-1.28 | $-0.58 |
| Mar 2025 | $-3.26 | $-1.71 | +$1.55 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… | 2026-0… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$1.0M | -$1.1M | -$2.7M | -$1.0M | -$2.2M |
Fundamentals Trend
| Metric | 2025-07-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -151.2% | -95.1% | -151.2% | -151.2% | -151.2% | -137.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.03 | 6.58 | 6.03 | 6.03 | 6.03 | 6.58 |
Key Ratios
ROA (TTM)
-116.5%
P/B
1.1
EPS (TTM)
$-4.88
CF/Share
$-2.35
52W High
$11.70
52W Low
$1.88
$1.88
52-Week Range
$11.70
Financial Health
Free Cash Flow
-$1.7M
Cash
$2.7M
As of Jan 31, 2026
How does ALZN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ALZN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
55%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ALZN profitability vs Biotechnology peers
ROE
-137.3%
▼
104%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-116.5%
▼
149%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ALZN financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.6
▲
48%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
-0.2
▼
125%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ALZN fundamentals radar
ALZN
Peer median
Industry
ALZN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALZN vs peers: key metrics
Top Holders
Top 5: 5.47%DRW Securities, LLC
3.06%
$122K
Geode Capital Management, L…
0.72%
$29K
UBS Group AG
0.65%
$26K
Vanguard Group Inc
0.57%
$23K
Morgan Stanley
0.47%
$19K
As of Dec 31, 2025
Latest News
No related news yet